…
Hawkins, Inc. operates as a water treatment and specialty ingredients company in the United States. The company operates through three segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. The Water Treatment segment provides chemicals, filtration media and systems, equipment, services and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agricultural water. This segment also sells and services equipment, including tanks, valves, and pumps. The Food and Health Sciences segment provide ingredient distribution, processing, and formulation solutions, such as base chemistry, acid-based reactions, minerals, vitamins and amino acids, excipients, botanicals and herbs, sweeteners and enzymes, fertilizers, and food-grade and pharmaceutical salts and ingredients to nutrition, food, pharmaceutical, and agricultural markets. The Industrial Solutions segment offers industrial chemicals, products, and services such as acids and alkalis, liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide to industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing industries. It also repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals. Hawkins, Inc. was founded in 1938 and is headquartered in Roseville, Minnesota.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Hawkins, Inc. is a distributor and contract blender of specialty chemicals serving water treatment, industrial, municipal and food/pharmaceutical customers across the U.S. Long-term growth may be supported by steady demand for water treatment, regulatory-driven chemical needs, recurring supply contracts and expansion of value-added blending services, while its regional distribution network appears positioned to preserve customer relationships.
Key risks include exposure to raw-material price volatility and supply-chain disruptions, regulatory compliance and competition from larger chemical distributors that could pressure margins and growth.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Income before tax | 109.34M | 114.38M | 101.14M | 82.58M | 69.98M |
| Net income | 81.55M | 84.34M | 75.36M | 60.04M | 51.54M |
| Selling general administrative | 123.76M | 106.36M | 89.60M | 76.97M | 75.33M |
| Gross profit | 223.75M | 212.74M | 193.64M | 165.12M | 146.52M |
| Reconciled depreciation | 52.54M | 39.95M | 31.80M | 27.44M | 24.13M |
| Ebit | 122.85M | 119.81M | 105.43M | 88.15M | 71.19M |
| Ebitda | 175.39M | 159.76M | 137.23M | 115.26M | 95.51M |
| Depreciation and amortization | 52.54M | 39.95M | 31.80M | 27.11M | 24.32M |
| Non operating income net other | - | - | - | -0.33M | 0.19M |
| Operating income | 115.12M | 120.54M | 104.04M | 88.15M | 71.19M |
| Other operating expenses | 968.58M | 853.89M | 815.13M | 846.95M | 703.35M |
| Interest expense | 13.51M | 5.43M | 4.28M | 5.23M | 1.40M |
| Tax provision | 27.79M | 30.04M | 25.78M | 22.54M | 18.44M |
| Net interest income | -13.51M | -5.43M | -4.28M | -5.23M | -1.40M |
| Income tax expense | 27.79M | 30.04M | 25.78M | 22.54M | 18.44M |
| Total revenue | 1083.70M | 974.43M | 919.16M | 935.10M | 774.54M |
| Total operating expenses | 108.64M | 92.19M | 89.60M | 76.97M | 75.33M |
| Cost of revenue | 859.94M | 761.69M | 725.53M | 769.98M | 628.02M |
| Total other income expense net | -5.78M | -6.16M | -2.89M | -5.57M | -1.22M |
| Net income from continuing ops | 81.55M | 84.34M | 75.36M | 60.04M | 51.54M |
| Net income applicable to common shares | - | - | - | 60.04M | 51.54M |
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Total assets | 1001.70M | 769.87M | 673.16M | 590.53M | 567.33M |
| Intangible assets | 232.89M | 150.12M | 116.63M | 73.06M | 80.19M |
| Other current assets | 8.66M | 7.42M | 6.60M | 6.45M | 6.43M |
| Total liab | 467.69M | 309.57M | 267.13M | 240.52M | 264.73M |
| Total stockholder equity | 534.01M | 460.29M | 406.03M | 350.02M | 302.60M |
| Deferred long term liab | - | - | - | 23.80M | 23.42M |
| Other current liab | 40.43M | 33.13M | 35.06M | 27.25M | 23.20M |
| Common stock | 0.21M | 0.21M | 0.21M | 0.21M | 0.21M |
| Capital stock | 0.21M | 0.21M | 0.21M | 0.21M | 0.21M |
| Retained earnings | 500.14M | 434.26M | 364.55M | 302.42M | 254.38M |
| Other liab | - | - | - | - | 38.47M |
| Good will | 223.04M | 135.41M | 103.40M | 77.40M | 77.40M |
| Other assets | - | - | 0.00M | - | 7.78M |
| Cash | 3.91M | 5.10M | 7.15M | 7.57M | 3.50M |
| Total current liabilities | 104.84M | 107.14M | 103.31M | 90.87M | 101.47M |
| Current deferred revenue | 1.58M | - | 1.94M | - | - |
| Net debt | 257.54M | 157.54M | 101.11M | 112.77M | 132.86M |
| Short term debt | 3.00M | 12.81M | 9.91M | 9.91M | 11.57M |
| Short long term debt | - | 9.91M | 9.91M | 9.91M | 9.91M |
| Short long term debt total | 261.46M | 162.64M | 108.26M | 120.33M | 136.36M |
| Other stockholder equity | 32.68M | 24.09M | 38.15M | 44.44M | 46.72M |
| Property plant equipment | - | - | - | 185.80M | 161.85M |
| Total current assets | 231.47M | 230.69M | 202.83M | 232.04M | 227.74M |
| Net tangible assets | - | - | - | 350.02M | 302.60M |
| Net receivables | 140.69M | 134.66M | 114.48M | 129.25M | 122.83M |
| Long term debt | 244.00M | 138.91M | 88.82M | 101.73M | 115.64M |
| Inventory | 78.20M | 83.51M | 74.60M | 88.78M | 94.98M |
| Accounts payable | 59.84M | 61.20M | 56.39M | 53.70M | 66.69M |
| Accumulated other comprehensive income | 0.98M | 1.73M | 3.12M | 2.94M | 1.29M |
| Common stock total equity | - | - | - | 0.21M | 0.21M |
| Retained earnings total equity | - | - | - | 302.42M | 254.38M |
| Non currrent assets other | 14.50M | 12.51M | 10.20M | -11.77M | 9.54M |
| Non current assets total | 770.23M | 539.18M | 470.33M | 358.49M | 339.59M |
| Capital lease obligations | 17.46M | 10.92M | 9.53M | 8.69M | 10.80M |
| Long term debt total | - | - | - | 101.73M | 115.64M |
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Investments | - | -127.95M | -122.50M | -41.23M | -49.76M |
| Change to liabilities | - | - | - | -9.04M | 28.07M |
| Total cashflows from investing activities | -224.10M | -127.95M | - | -41.23M | -49.76M |
| Net borrowings | 95.00M | 50.00M | - | -14.00M | 26.71M |
| Total cash from financing activities | 78.58M | 14.81M | -37.41M | -32.10M | 7.42M |
| Change to operating activities | - | - | - | - | -2.20M |
| Net income | 81.55M | 84.34M | 75.36M | 60.04M | 51.54M |
| Change in cash | -1.19M | -2.05M | -0.41M | 4.07M | 0.50M |
| Begin period cash flow | 5.10M | 7.15M | 7.57M | 3.50M | 3.00M |
| End period cash flow | 3.91M | 5.10M | 7.15M | 7.57M | 3.50M |
| Total cash from operating activities | 144.33M | 111.10M | 159.50M | 77.40M | 42.84M |
| Issuance of capital stock | 3.04M | 2.66M | 2.24M | 2.01M | 1.77M |
| Depreciation | 52.54M | 39.95M | 31.80M | 27.44M | 24.13M |
| Other cashflows from investing activities | 1.25M | 0.54M | - | 7.09M | -21.24M |
| Dividends paid | 15.66M | 14.63M | 13.24M | 12.00M | 11.06M |
| Change to inventory | 10.05M | -6.57M | 19.92M | 4.72M | -30.03M |
| Change to account receivables | -2.47M | -11.23M | 21.40M | -6.39M | -30.53M |
| Sale purchase of stock | -3.03M | -23.22M | -11.27M | -8.11M | -10.01M |
| Other cashflows from financing activities | -0.76M | 29.44M | -2.14M | 45.00M | 41.71M |
| Change to netincome | - | - | - | 1.06M | 2.67M |
| Capital expenditures | 58.24M | 41.10M | 40.15M | 48.32M | 28.51M |
| Change receivables | - | - | - | -6.39M | -30.53M |
| Cash flows other operating | - | - | - | -0.43M | -3.02M |
| Cash and cash equivalents changes | - | - | - | 4.07M | 0.50M |
| Change in working capital | 2.38M | -24.39M | 47.02M | -13.12M | -37.41M |
| Stock based compensation | 8.57M | 6.50M | 4.88M | 3.83M | 3.82M |
| Other non cash items | -3.77M | 4.23M | 29.88M | -0.56M | 2.25M |
| Free cash flow | 86.09M | 70.00M | 119.35M | 29.08M | 14.32M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HWKN Hawkins Inc |
-0.33 0.21% |
153.73 | 31.47 | 28.65 | 2.29 | 4.59 | 2.51 | 15.85 |
| LIN Linde plc Ordinary Shares |
-5.01 0.99% |
503.15 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
0.65 1.67% |
39.60 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
- -% |
192.32 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
9.30 2.90% |
330.10 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Hawkins, Inc. operates as a water treatment and specialty ingredients company in the United States. The company operates through three segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. The Water Treatment segment provides chemicals, filtration media and systems, equipment, services and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agricultural water. This segment also sells and services equipment, including tanks, valves, and pumps. The Food and Health Sciences segment provide ingredient distribution, processing, and formulation solutions, such as base chemistry, acid-based reactions, minerals, vitamins and amino acids, excipients, botanicals and herbs, sweeteners and enzymes, fertilizers, and food-grade and pharmaceutical salts and ingredients to nutrition, food, pharmaceutical, and agricultural markets. The Industrial Solutions segment offers industrial chemicals, products, and services such as acids and alkalis, liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide to industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing industries. It also repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals. Hawkins, Inc. was founded in 1938 and is headquartered in Roseville, Minnesota.
| Name | Title | Year Born |
|---|---|---|
| Mr. Patrick H. Hawkins | CEO, Pres & Director | 1971 |
| Mr. Jeffrey P. Oldenkamp | Exec. VP, CFO & Treasurer | 1972 |
| Mr. Drew M. Grahek | VP of Operations | 1971 |
| Mr. Richard G. Erstad | VP, Gen. Counsel & Sec. | 1964 |
| Mr. Daniel J. Stauber | Director | 1962 |
| Ms. Shirley A. Rozeboom | VP of Health & Nutrition | 1962 |
| Mr. Paul Siler | Corp. Controller | NA |
| Mr. Patrick H. Hawkins | CEO, President & Director | 1971 |
| Mr. Jeffrey P. Oldenkamp | Executive VP, CFO & Treasurer | 1972 |
| Mr. Drew M. Grahek | Vice President of Operations | 1971 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.